In the media 8 Jul 2026 No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials The Print
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 15 Jul 2026 Dengue outbreak complicates Bangladesh measles crisis response The Telegraph
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Press releases 13 Jul 2026 DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
Scientific articles 9 Jul 2026 Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring PLOS Neglected Tropical Diseases
In the media 9 Jul 2026 Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy The Indian Express
Press Releases Translations 8 Jul 2026 Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia
Press Releases Translations 8 Jul 2026 Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India
Scientific articles 29 Mar 2024 Practical Synthesis of 6-Amino-1-hydroxy-2,1-benzoxaborolane: A Key Intermediate of DNDI-6148 Organic Process Research & Development
Scientific articles 26 Mar 2024 High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae eBioMedicine
Scientific articles 26 Mar 2024 Towards enhanced control of mycetoma: a roadmap to achieve the UN’s sustainable development goals by 2030 Transactions of The Royal Society of Tropical Medicine and Hygiene
Scientific articles 15 Mar 2024 Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers Clinical and Translational Science
Scientific articles 21 Feb 2024 Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development PLOS Neglected Tropical Diseases
Scientific articles 20 Feb 2024 A sample-centric and knowledge-driven computational framework for natural products drug discovery ACS Central Science
Scientific articles 31 Jan 2024 Onchocerciasis drug discovery: In vitro evaluation of FDA-approved drugs against onchocerca gutturosa in Gambia Pharmaceutics
Scientific articles 30 Jan 2024 Late-stage diversification of pyrazoles as antileishmanial agents ChemMedChem
Scientific articles 24 Jan 2024 Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains Antiviral Research
Scientific articles 23 Jan 2024 Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens iScience
Scientific articles 21 Jan 2024 Population pharmacokinetics of pediatric lopinavir/ritonavir oral pellets in children living with HIV in Africa Clinical Pharmacology and Therapeutics
Scientific articles 10 Jan 2024 Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial The Lancet Infectious Diseases
Scientific articles 25 Dec 2023 Madurastatins with imidazolidinone rings: Natural products or side-reaction products from extraction solvents? International Journal of Molecular Sciences
Scientific articles 15 Dec 2023 Facing the escalating burden of dengue: Challenges and perspectives PLOS Global Public Health
Scientific articles 13 Dec 2023 DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1 Science Translational Medicine
Scientific articles 13 Dec 2023 Short-course combination treatment for experimental chronic Chagas disease Science Translational Medicine